Snickpick Investment
Venture capitalSeoul · Seed–Series A
Investment thesis
Snickpick Investment invests in early-stage bio and healthcare technology companies. Its team consists of bio and healthcare industry experts who have founded biotech ventures and grown them into global bioenterprises. Leveraging this deep and diverse industry experience, the firm identifies companies with promising growth potential, then provides both investment and active support so these companies can realize their market value. The firm positions itself as a growth partner to venture businesses and follows a structured investment process spanning sourcing, IR, internal review, an investment review committee, post-investment and risk management, an exit review committee, and eventual exit.
Source: firm website, verified Aug 3, 2026.
Investments · 8 tracked
founders shown can be your intro pathFrequently asked questions
- What stage does Snickpick Investment invest at?
- Snickpick Investment invests at the Seed, Series A stages.
- What sectors does Snickpick Investment focus on?
- Snickpick Investment focuses on Biotech, Digital Health, Healthtech.
- Where is Snickpick Investment located?
- Snickpick Investment is headquartered in Seoul, KR.
Images
Similar investors
Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.
Lux Capital's portfolio page showcasing select companies across science and technology sectors including AI infrastructure, aerospace, biotech, and productivity software.
5AM Ventures is a life science venture capital firm founded in 2002 that invests primarily in private therapeutic companies, with a focus on biopharmaceuticals, drug delivery technologies, and life science instruments.
Sofinnova is an investment firm that partners with biotech companies from inception through growth, supporting drug development, the regulatory process, company building, and IPO.
Kaiser Permanente Ventures is the corporate venture capital arm investing in healthcare companies that address real needs and deliver value for patients, providers, healthcare delivery systems, and communities.